V-RULES: Real-World Effectiveness and Safety of CPX-351 for First-Line Treatment of Therapy-Related Acute Myeloid Leukemia (AML) or AML with Myelodysplasia-Related Changes in the US

Clinical Lymphoma, Myeloma & Leukemia · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles